Concerns over drug prices and medication nonadherence have led to a search for new strategies to lower health care costs and out-of-pocket spending by patients.1 One potentially powerful strategy is to present physicians with the price of medications and their alternatives before or during ordering. Real-time benefit tools (RTBTs) are intended to provide this information by drawing on information from pharmacy benefit plans and displaying patient-specific price information to clinicians at the time a prescription is written. Adoption and use of such technologies has been limited to date but will likely increase, as the Centers for Medicare & Medicaid Services (CMS) recently finalized a rule that Medicare Part D plan sponsors implement 1 or more RTBTs capable of integrating with at least 1 prescriber’s electronic prescribing system or electronic health record (EHR) by January 1, 2021.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Everson J, Frisse ME, Dusetzina SB. Real-Time Benefit Tools for Drug Prices. JAMA. 2019;322(24):2383–2384. doi:10.1001/jama.2019.16434
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: